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Pharmaceutics
diffusion or both mechanisms to generate slow release 
of drug to the gastrointestinal (GI) tract. In the diffusion 
system, the release of a drug is determined by its diffusion 
through a water insoluble polymer.[2] One such method 
to achieve controlled release is sintering of the polymer 
matrix in which a drug is dispersed and which controls drug 
release by diffusion through the matrix, by erosion of the 
matrix or by combination of both erosion and diffusion. 
Sintering is a better way for controlled release because of its 
less expensive scale up as well as reduced sintering time.[3]
Sintering is defined as the bonding of adjacent particle 
surfaces in a mass of powder or in a compact by 
application of heat.[4] Sintering retards drug release mainly 
by decreasing the porosity of the matrix.[5] This concept 
in pharmaceutical science is relatively recent but research 
interest relating to this process has been growing. Sintering 
INTRODUCTION
The objective in dosage form design is to optimize the 
delivery of medication so as to achieve a measure of control 
of therapeutic effect in the face of uncertain fluctuation in 
the in vivo environment in which drug release takes place.[1] 
There are several physical approaches by which the drug 
releases from a dosage form can be retarded. The majority 
of oral controlled release systems rely on dissolution, 
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ABSTRACT
The objective of the present study was to evaluate the effect of sintering condition on matrix formation and 
subsequent drug release from polymer matrix tablet for controlled release. The present study highlights the use 
of a microwave oven for the sintering process in order to achieve more uniform heat distribution with reduction 
in time required for sintering. We could achieve effective sintering within 8 min which is very less compared to 
conventional hot air oven sintering. The tablets containing the drug (propranolol hydrochloride) and sintering 
polymer (eudragit S-100) were prepared and kept in a microwave oven at 540 watt, 720 watt and 900 watt power 
for different time periods for sintering. The sintered tablets were evaluated for various tablet characteristics 
including dissolution study. Tablets sintered at 900 watt power for 8 min gave better dissolution profile compared 
to others. We conclude that microwave oven sintering is better than conventional hot air oven sintering process 
in preparation of controlled release tablets.
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is a simple and economic process to obtain controlled 
release of drug from the tablet with relatively less quantity 
of polymer and avoiding the granulation process in 
tableting. Many researchers have reported the use of the 
conventional hot air oven sintering process for controlled 
release of drug from tablets[6] and microwave oven sintering 
process for ceramic industry.[7]
A survey of the literature revealed the use of ethylene 
vinyl acetate, eudragit S-100 and eudragit L-100 as sintering 
polymers.[8] Use of some waxes like compritol and stearic 
acid is also reported in sintering.[9] Controlled release tablets 
for thermally stable drugs like rifampicin, theophylline and 
ketorolac tromethamine by sintering are reported.
Here, we have used microwave oven sintering for controlled 
release of drug from tablets. It offers several advantages 
over conventional hot air oven. Uniform heat distribution 
leads to uniform sintering compared to a conventional hot 
air oven where sintering occurs at the surface. The time 
required for sintering is also less so it is more economical 
than a conventional hot air oven. The contact time of drug 
with heat is very low compared to a conventional hot air 
oven with less chances of drug degradation.
In the present study, we have used eudragit S-100 as 
sintering polymer and propranolol Hydrochloride (HCL) 
as a model drug for controlled release.
MATERIALS AND METHODS
Materials
Propranolol HCL, eudragit S-100, talc and magnesium 
stearate and other ingredients were of laboratory grade and 
procured from Yarrow Chemical Products, Mumbai, India.
Methodology
Flow properties of  polymer-drug powder blend
The statics angle of repose was measured according to the 
fixed funnel and freestanding cone method. A funnel with 
the end of the stem cut perpendicular to its axis of symmetry 
was secured with its tip 2 cm above a graph paper placed 
on a flat horizontal surface. Powder was carefully poured 
through the funnel until the apex of the cone thus formed 
just reached the tip of the funnel. The mean diameter and 
the tangent of the angle of repose were determined.
Compressibility on taping was measured with a sample of 
25 g placed in a 100 ml graduated cylinder and the occupied 
volume (Vo) was determined. After 10 and 500 vibrations, 
occupied volumes were determined and reported as V10 and 
V500, respectively. With these data the compressibility index was 
calculated using the equation: CI = (d500 – d10/d500) × 100.[10]
Preparation of  tablets
From a review of the literature, it was determined that 
around 25% of polymer is required for controlled release 
matrix tablet by sintering technique. Hence, in preliminary 
trials the polymer was taken at 25% of total tablet weight. 
Propranolol hydrochloride and eudragit S-100 were 
accurately weighed using Sartorius monopan balance in the 
required quantity as shown in Table 1. Drug and polymer 
were mixed by using a mortar pestle initially for 3 min and 
finally in a glass bottle by tumbling action for additional 3 
min. Then the talc (1%) and magnesium stearate (0.5%) 
were added as glidant and lubricant, respectively, and 
mixed thoroughly for 2 min. Finally, the powder mass was 
compressed into tablets using rotary tablet compression 
machine (Rimek Minipress, Karnavati Engg. Pvt. Ltd, 
Ahmedabad, India) at room temperature.
Sintering of  tablets
Sintering of tablets was performed using microwave oven 
(Intellocook, LG, India). The fluffy matrix tablets were put 
into a glass beaker and the beaker was closed by using petri 
dish. Then this assembly was put into the microwave oven. 
The tablets were irradiated in the microwave oven at different 
powers (540 watt, 720 watt and 900 watt) for different 
time durations. Finally, the sintered tablets were carefully 
removed from the oven and were evaluated for various tablet 
parameters as well as dissolution study. The prepared tablets 
were also sintered using hot air oven at 80oC for 90 min.
Weight variation test
Twenty tablets were selected at random, weighed and the 
average weight was calculated. Not more than two of the 
individual weights should deviate from the average weight 
by more than 5%.
Friability
For each formulation, pre-weighed tablet samples 
(20 tablets) were placed in the friabilator (Electrolab, 
Mumbai, India) which was then operated for 100 
revolutions. The tablets were dedusted and reweighed. 
Conventional compressed tablets that lose <0.5 to 1% of 
Table 1: Composition of propranolol hydrochloride 
tablets
Ingredients Quantity
Propranolol HCL 80 mg
Eudragit S-100 (%) 25
Magnesium stearate (%) 0.5
Talc (%) 1178   Journal of Young Pharmacists Vol 3 / No 3
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their weight are considered acceptable. For sintered tablets 
the friability was almost negligible [Table 2].
Hardness
Hardness of tablet was determined before and after 
sintering using Pfizer hardness tester (Type 0-12 Janki, 
India). Hardness of sintered tablets is reported in Table 3.
Drug content determination
Twenty tablets were weighed and powdered in a glass 
mortar. Quantity of powder equivalent to 20 mg of 
propranolol HCL was accurately weighed and transferred 
in a 100 ml volumetric flask containing 20 ml of water. 
The flask was shaken for 10 min and 30 ml of methanol 
was added. The flask was shaken for an additional 10 min. 
Finally, the volume was made up to the mark with methanol. 
The solution was filtered through a 0.45 μ filter and was 
analyzed by Ultraviolet/Visible Spectrophotometer (UV-
1800, Shimadzu, Kyoto, Japan) at 290 nm.
Fourier transfer infrared spectroscopy
Fourier transfer infrared (FTIR) spectra of propranolol 
HCL, eudragit S-100, a physical mixture of propanolol 
HCL:eudragit S-100 (3:1) before and after heat treatment 
were recorded using KBr mixing method on FTIR 
instrument available at the central instrument laboratory 
of the institute (FTIR-1700, Shimadzu, Kyoto, Japan).
In vitro dissolution rate study
The in vitro dissolution study was conducted for all 
the sintered tablet formulations using United States 
Pharmacopoeia (USP) Type I dissolution test apparatus 
(Electrolab, Mumbai, India). Dissolution test was 
carried out for a total period of 12 h, using 0.1 N HCL   
(900 ml) as dissolution medium for the first 2 h, and pH 
6.8 phosphate buffer for the rest of the time period. At 
an appropriate time interval, 5 ml sample was withdrawn 
and replaced with same volume of the fresh dissolution 
medium. The absorbance of this sample was measured 
at 290 nm against blank using Shimadzu UV-1800 
double- beam spectrophotometer to determine the amount 
of propranolol hydrochloride released from the tablets.
Kinetic modeling of  dissolution data
To determine the release kinetic of the drug, various 
mathematical models were applied like Higuchi diffusion 
model,[11] Korsmeyer-Peppas model,[12] Hixon-Crowell 
model,[13] zero order model and first order model. 
Correlation coefficient (r2) and diffusion coefficient (d) of 
these models are mentioned in Table 4.
RESULTS AND DISCUSSION
Pharmaceutical industries need to characterize the flow 
property of the powder that makes it possible to estimate 
their suitability for the directly compressible excipients. 
In this work we have used some of these tests. Angle of 
repose and compressibility index on taping were used for 
characterizing the flow property of the powder. These tests 
are used routinely to characterize the bulk solid before 
compression to optimize flow property in the experimental 
formulation. Angle of repose and compressibility index 
Table 3: Hardness of tablets at different power in kg/cm2
NST MOST1 MOST2 MOST3 HOST
2.8 3 3.7 4.3 4
2.9 3 3.9 4.5 3.9
2.9 2.9 3.6 4.3 3.8
2.8 2.9 3.7 4.4 4
2.7 3 3.7 4.3 4.2
2.9 3 3.8 4.5 3.9
NST: Non-sintered tablets, MOST1: tablets sintered at 540 watt power for 15 min 
with microwave oven, MOST2: tablets sintered at 720 watt power for 10 min 
with microwave oven, MOST3: tablets sintered at 800 watt power for 8 min with 
microwave oven, HOST: tablets sintered at 80oC for 90 min with hot air oven
Table 2: Tablet parameters
Batch Content 
uniformity (%)
Weight 
variation (mg)
Friability (%)
NST  94 100 ± 3.0 0.06
MOST1 95 100 ± 2.5 0.02
MOST2 94 100 ± 3.0 0.02
MOST3 95 100 ± 2.0 0
HOST 78.8 100 ± 2.5 0.01
NST: Non-sintered tablets, MOST1: tablets sintered at 540 watt power for 15 min 
with microwave oven, MOST2: tablets sintered at 720 watt power for 10 min 
with microwave oven, MOST3: tablets sintered at 800 watt power for 8 min with 
microwave oven, HOST: tablets sintered at 80oC for 90 min with hot air oven
Table 4: Kinetic treatment of the release data from sintered tablets
Model MOST1 MOST2 MOST3 HOST
r2 n K r2 n K r2 n K r2 n K
Zero order 0.85 0.91 0.92 0.86
First order 0.80 0.84 0.85 0.80
Higuchi 0.92 0.96 0.95 0.92
Korsmeyer Peppas 0.95 0.29 0.52 0.97 0.33 0.46 0.96 0.31 0.46 0.94 0.31 0.44
Hixon Crowell −0.80 −0.87 −0.87 −0.82
NST: Non-Sintered Tablets, MOST1: tablets sintered at 540 watt power for 15 min with microwave oven, MOST2: tablets sintered at 720 watt power for 10 min with microwave 
oven, MOST3: tablets sintered at 800 watt power for 8 min with microwave oven, HOST: tablets sintered at 80oC for 90 min with hot air ovenJournal of Young Pharmacists Vol 3 / No 3  179
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of powder mixture were found to be 27.23o and 15%, 
respectively which indicates better flow.
Tablets from all formulations passed the test for weight 
uniformity. Not more than two tablets differed from the 
average weight by more than 5% and no tablet differed 
by more than 10%. Tablets of all formulations passed the 
test for friability. The hardness of tablets before and after 
sintering is shown in Table 3. The results indicate that as the 
power of sintering increases hardness increases. The very 
low hardness obtained when the tablets were sintered at low 
power indicates that the main forces holding the particles 
together are probably Van der Waals and mechanical 
forces due to interlocking of irregularities on the surfaces 
of the particles. Increasing the power increased the tablet 
hardness probably due to the fusion of polymer granules 
or formation of a welded bond between particles. FTIR 
study revealed neither drug degradation nor any interaction 
between drug and the sintering polymer as evident from 
the FTIR spectra [Figures 1-4].
Sustained drug release was observed from the sintered 
tablet matrices during dissolution study compared to non-
sintered tablets [Figure 5]. From the preliminary studies 
of sintering and subsequent dissolution it was found that 
sintering at a power less than 540 watt was not sufficient 
to sustain the drug release. The power for sintering was 
gradually increased from 540 watt to 900 watt. The time 
required for effective sintering at 540 watt was 15 min 
and was decreased as the power was increased. Sintering 
at 900 watt for 10 min resulted in browning of the tablets. 
Hence, the optimum time of 8 min was selected for 
sintering at 900 watt. Higher power options were not 
considered as that may cause excessive heating leading to 
degradation. From Figure 5 it is also evident that hot air 
oven-sintered tablets show similar sustained drug release as 
microwave-sintered tablets. The drug content in the tablets 
sintered using hot air oven was 78.8% [Table 2] indicating 
drug degradation.
At the end of 12 h, the shape of matrices was not disturbed 
suggesting that the release of the drug is controlled by 
diffusion from the matrices. The diffusion-controlled 
drug release was also supported by the kinetic of release 
data as the data were fitted to the Higuchi diffusion 
model [Table 4]. Higuchi has described the drug release 
mechanism from matrix dosage forms using the equation: 
Q = [D (2W-Cs) Cst]     1/2. In the equation, D is the diffusion 
Figure 1: FTIR spectra of propranolol hydrochloride Figure 2: FTIR spectra of eudragit S-100
Figure 3: FTIR spectra of physical mixture of eudragit S-100 and 
propranolol HCl Figure 4: FTIR spectra of sintered tablet of propranolol HCl180   Journal of Young Pharmacists Vol 3 / No 3
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coefficient of the drug in the matrices, W is the total 
amount of the drug per unit volume of the matrices, Cs is 
the solubility of the drug in the matrices and t is the drug 
release time. When W>>Cs, the above equation can be 
simplified to: Q = [2WDCst]1/2
. This equation indicates that 
the amount of drug release is proportional to the square 
root of time for the diffusional release of a drug from the 
matrix type system. The linear correlation coefficient of the 
slope shown in Table 4 indicates that the drug release from 
the eudragit S-100 polymeric matrix follows the Higuchi 
diffusion model. It had been reported that the eudragit 
S-100 matrices sintered at increased power might result in a 
greater extent of sintering due to firmness between eudragit 
S-100 particles. To gain some insight into the drug release 
mechanism, a very simple and semi-empirical equation to 
describe the drug release from the polymeric system, the 
power law (Korsmeyer-Peppas model, Mt/M∞ = K tn) was 
also applied. The value of the diffusion exponent obtained 
was <0.5 indicating Fickian diffusion of the drug from 
sintered tablet matrices.
CONCLUSION
Among the different strategies employed for the design 
of a controlled release dosage form, sintering technique 
for the preparation of polymer matrices for the controlled 
release of propranolol is an alternative technique. This new 
method for controlling the release rate has been developed 
and tested here using microwave oven for sintering which 
gives more uniform heat distribution with less time required 
than a conventional hot air oven.
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Figure 5:  Comparative  dissolution  profile  of  tablets   
(NST= Non-sintered Tablets, MOST1 = tablets sintered at 540 
watt power for 15 min with microwave oven, MOST2 = tablets 
sintered at 720 watt power for 10 min with microwave oven,   
MOST3= tablets sintered at 800 watt power for 8 min with microwave oven,   
HOST= tablet sintered at 80oC for 90 min with hot air oven)